TRACIE WEHI

TRodelvy use in AdvanCed TrIple Negative BrEast Cancer in Australia (TRACIE). Evaluating the safety and efficacy of sacituzumab govitecan (SG) in patients with previously treated unresectable locally advanced or metastatic triple negative breast cancer (advanced TNB) through creation of a patient registry using secondary data.

Enquire

Trial overview

Clinical Area

Medical Oncology

Disease

Breast

Disease site

Breast

Study Phase

Observational

Trial Identifiers

Registration number: ACTRN12623000931673

https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12623000931673

GenesisCare Location(s)

St Leonards (North Shore Health Hub)

North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia

(02) 8037 4100

admin.northshore@genesiscare.com

Find out more Get directions

Principal Investigator(s)

Medical Oncologist

Dr Sally Baron-Hay

FRACP MBBS

View Profile

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.

First name *

Last name *

Email *

Phone *

State *

Postcode *

What is the reason for enquiry?

How would you prefer to be contacted? *

Phone

By submitting you acknowledge we will use the information you are providing to contact you about your enquiry. For more information about how we handle your personal information, please refer to the GenesisCare Privacy Policy.

Disclaimer:

This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.

Disclaimer: